Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-066420

Chief Financial Officer acquired 6,986 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Smith Hunter C Chief Financial Officer 2025-07-07 Option exercise +6,986 $6.88 $48,064 116,915 D
Derivatives
Smith Hunter C Chief Financial Officer 2025-07-07 Option exercise · Stock Options (Right to Buy) −6,986 70,208 D
Loading xslF345X05/tm2520047-1_4seq1.xml…